Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response
The findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.
Read MoreThe findings in animal models warrant continuing investigations to develop a novel, more effective and longer-lasting cancer therapy.
Read MoreThese studies improve our understanding of both human biology and practical clinical issues.
Read MoreThe findings open new possibilities for novel therapies to provide much needed relief to patients with this condition.
Read MoreThe researchers also developed a strategy that reduced tumor growth and improved survival in tumor-bearing mice.
Read MoreThe researchers identified ways to accelerate the restoration of the normal immune response and the efficacy of immunotherapies in animal models.
Read MoreResearchers discussed the latest cutting-edge, translational and clinical research focusing on pediatric hematology and oncology.
Read MoreThe findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.
Read MoreGlyNAC – a combination of precursors of the natural antioxidant glutathione – improved or reversed age-associated cognitive decline in old mice and improved multiple associated defects in the aging brain.
Read MoreThe findings open new avenues to investigate mechanisms that lead to this disorder, offering ideas toward a future treatment for the disease.
Read MoreNeurons trigger a complex pattern of events, some of them unexpected, that direct astrocyte development in a region-specific manner.
Read More